Developments In East-West Pharma Simcere Pharma, which makes generic drugs for the Chinese market, filed for an IPO that could raise up to $120 million. The company intends to list shares on the NYSE under the symbol SCR. In 2006, Simcere earned a profit of $22 million on $122 million of revenue. Compared to the prior year, profits rose almost 70% on a 25% increase in revenue. The company makes 35 pharmaceutical products at the moment, though it has approval to manufacture 100 other products. More details...